| 1 | [SID26724316] | Active | Potency | 15.1014 | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) [AID588342, Type: confirmatory] | Luciferase [Photinus pyralis] [gi:160794] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Active | | Potency | 15.1014 [uM] | | BioAssay | qHTS profiling assay for firefly luciferase inhibitor/activator using purifed enzyme and Km concentrations of substrates (counterscreen for miR-21 project) | | AID | 588342 | | BioAssay type | confirmatory | | Target | Luciferase [Photinus pyralis] [gi:160794] | | PubMed | | | Data Table |  |
|
| 2 | [SID92709325] | Active | | | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other] | LYPLA2 gene product [Homo sapiens] [gi:9966764] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 92709325 | | CID | 4412828 | | Outcome | Active | | BioAssay | Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition | | AID | 652029 | | BioAssay type | other | | Target | LYPLA2 gene product [Homo sapiens] [gi:9966764] | | PubMed | | | Data Table |  |
|
| 3 | [SID26724316] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of lysophospholipase 2 (LYPLA2). [AID2232, Type: screening] | lysophospholipase II [Homo sapiens] [gi:4581413] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based biochemical high throughput confirmation assay to identify inhibitors of lysophospholipase 2 (LYPLA2). | | AID | 2232 | | BioAssay type | screening | | Target | lysophospholipase II [Homo sapiens] [gi:4581413] | | PubMed | | | Data Table |  |
|
| 4 | [SID26724316] | Active | | | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). [AID2177, Type: screening] | lysophospholipase II [Homo sapiens] [gi:4581413] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Active | | BioAssay | Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2). | | AID | 2177 | | BioAssay type | screening | | Target | lysophospholipase II [Homo sapiens] [gi:4581413] | | PubMed | | | Data Table |  |
|
| 5 | [SID26724316] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 6 | [SID26724316] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 7 | [SID26724316] | Inactive | Potency | 10 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | Potency | 10 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 8 | [SID26724316] | Inactive | Potency | 10 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | Potency | 10 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 9 | [SID26724316] | Inactive | Potency | 31.6228 | qHTS Assay for Inhibitors of the HIV-1 protein Vpr [AID651644, Type: confirmatory] | Vpr [Human immunodeficiency virus 1] [gi:28872817] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | Potency | 31.6228 [uM] | | BioAssay | qHTS Assay for Inhibitors of the HIV-1 protein Vpr | | AID | 651644 | | BioAssay type | confirmatory | | Target | Vpr [Human immunodeficiency virus 1] [gi:28872817] | | PubMed | | | Data Table |  |
|
| 10 | [SID26724316] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9 [AID624416, Type: screening] | Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1] [gi:9629363] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9 | | AID | 624416 | | BioAssay type | screening | | Target | Envelope surface glycoprotein gp160, precursor [Human immunodeficiency virus 1] [gi:9629363] | | PubMed | | | Data Table |  |
|
| 11 | [SID26724316] | Inactive | IC50 | | uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1 [AID1565, Type: confirmatory] | phosphoethanolamine/phosphocholine phosphatase isoform 1 [Homo sapiens] [gi:219689097] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | uHTS absorbance assay for the identification of compounds that inhibit PHOSPHO1 | | AID | 1565 | | BioAssay type | confirmatory | | Target | phosphoethanolamine/phosphocholine phosphatase isoform 1 [Homo sapiens] [gi:219689097] | | PubMed | | | Data Table |  |
|
| 12 | [SID26724316] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels [AID2156, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels | | AID | 2156 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 13 | [SID26724316] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels [AID2156, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels | | AID | 2156 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 14 | [SID26724316] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels [AID2239, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels | | AID | 2239 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 15 | [SID26724316] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels [AID2239, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels | | AID | 2239 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 16 | [SID26724316] | Inactive | | | HTS Assay for Peg3 Promoter Inhibitors [AID588405, Type: screening] | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | HTS Assay for Peg3 Promoter Inhibitors | | AID | 588405 | | BioAssay type | screening | | Target | Ppp1r15a gene product [Rattus norvegicus] [gi:78486550] | | PubMed | | | Data Table |  |
|
| 17 | [SID26724316] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction. [AID2280, Type: screening] | defective in Germ Line Development family member (gld-1) [Caenorhabditis elegans] [gi:17507875] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction. | | AID | 2280 | | BioAssay type | screening | | Target | defective in Germ Line Development family member (gld-1) [Caenorhabditis elegans] [gi:17507875] | | PubMed | | | Data Table |  |
|
| 18 | [SID26724316] | Inactive | | | uHTS identification of SKN-1 Inhibitors in a fluoresence assay [AID624304, Type: screening] | Protein SKN-1, isoform b [Caenorhabditis elegans] [gi:25148072] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | uHTS identification of SKN-1 Inhibitors in a fluoresence assay | | AID | 624304 | | BioAssay type | screening | | Target | Protein SKN-1, isoform b [Caenorhabditis elegans] [gi:25148072] | | PubMed | | | Data Table |  |
|
| 19 | [SID26724316] | Inactive | | | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen [AID1832, Type: screening] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen | | AID | 1832 | | BioAssay type | screening | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 20 | [SID26724316] | Inactive | | | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen [AID1832, Type: screening] | Zinc finger protein mex- [gi:55976631] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen | | AID | 1832 | | BioAssay type | screening | | Target | Zinc finger protein mex- [gi:55976631] | | PubMed | | | Data Table |  |
|
| 21 | [SID26724316] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) [AID652126, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12) | | AID | 652126 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 22 | [SID26724316] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12) [AID652067, Type: screening] | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12) | | AID | 652067 | | BioAssay type | screening | | Target | Protein DAF-12, isoform a [Caenorhabditis elegans] [gi:71987181] | | PubMed | | | Data Table |  |
|
| 23 | [SID26724316] | Inactive | | | uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay [AID493011, Type: screening] | APOBEC3A gene product [Homo sapiens] [gi:21955158] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay | | AID | 493011 | | BioAssay type | screening | | Target | APOBEC3A gene product [Homo sapiens] [gi:21955158] | | PubMed | | | Data Table |  |
|
| 24 | [SID26724316] | Inactive | Potency | | qHTS for Inhibitors of Vif-A3F Interactions: qHTS [AID602313, Type: confirmatory] | APOBEC3F gene product [Homo sapiens] [gi:22907044] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Vif-A3F Interactions: qHTS | | AID | 602313 | | BioAssay type | confirmatory | | Target | APOBEC3F gene product [Homo sapiens] [gi:22907044] | | PubMed | | | Data Table |  |
|
| 25 | [SID26724316] | Inactive | | | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB) [AID504411, Type: screening] | sn1-specific diacylglycerol lipase beta isoform 1 [Homo sapiens] [gi:218931251] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB) | | AID | 504411 | | BioAssay type | screening | | Target | sn1-specific diacylglycerol lipase beta isoform 1 [Homo sapiens] [gi:218931251] | | PubMed | | | Data Table |  |
|
| 26 | [SID26724316] | Inactive | | | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB) [AID504411, Type: screening] | sn1-specific diacylglycerol lipase beta isoform 1 [Homo sapiens] [gi:218931251] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB) | | AID | 504411 | | BioAssay type | screening | | Target | sn1-specific diacylglycerol lipase beta isoform 1 [Homo sapiens] [gi:218931251] | | PubMed | | | Data Table |  |
|
| 27 | [SID26724316] | Inactive | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B. [AID1947, Type: screening] | Fam108b protein [Mus musculus] [gi:21595511] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B. | | AID | 1947 | | BioAssay type | screening | | Target | Fam108b protein [Mus musculus] [gi:21595511] | | PubMed | | | Data Table |  |
|
| 28 | [SID26724316] | Inactive | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B. [AID1947, Type: screening] | Fam108b protein [Mus musculus] [gi:21595511] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B. | | AID | 1947 | | BioAssay type | screening | | Target | Fam108b protein [Mus musculus] [gi:21595511] | | PubMed | | | Data Table |  |
|
| 29 | [SID26724316] | Inactive | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B. [AID1947, Type: screening] | Fam108b protein [Mus musculus] [gi:21595511] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B. | | AID | 1947 | | BioAssay type | screening | | Target | Fam108b protein [Mus musculus] [gi:21595511] | | PubMed | | | Data Table |  |
|
| 30 | [SID26724316] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1) [AID651572, Type: screening] | Arfgap1 gene product [Rattus norvegicus] [gi:21489979] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1) | | AID | 651572 | | BioAssay type | screening | | Target | Arfgap1 gene product [Rattus norvegicus] [gi:21489979] | | PubMed | | | Data Table |  |
|
| 31 | [SID26724316] | Inactive | | | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling [AID588627, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling | | AID | 588627 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 32 | [SID26724316] | Inactive | | | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling [AID588627, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling | | AID | 588627 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 33 | [SID26724316] | Inactive | | | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling [AID588675, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling | | AID | 588675 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 34 | [SID26724316] | Inactive | | | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling [AID588675, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling | | AID | 588675 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 35 | [SID26724316] | Inactive | | | Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling [AID588676, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling | | AID | 588676 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 36 | [SID26724316] | Inactive | | | Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling [AID588676, Type: screening] | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling | | AID | 588676 | | BioAssay type | screening | | Target | MAS-related GPR member X1 [Homo sapiens] [gi:195969650] | | PubMed | | | Data Table |  |
|
| 37 | [SID26724316] | Inactive | | | Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA) [AID651718, Type: screening] | MSRA protein [Bos taurus] [gi:73586699] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA) | | AID | 651718 | | BioAssay type | screening | | Target | MSRA protein [Bos taurus] [gi:73586699] | | PubMed | | | Data Table |  |
|
| 38 | [SID26724316] | Inactive | | | Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA) [AID602163, Type: screening] | MSRA protein [Bos taurus] [gi:73586699] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA) | | AID | 602163 | | BioAssay type | screening | | Target | MSRA protein [Bos taurus] [gi:73586699] | | PubMed | | | Data Table |  |
|
| 39 | [SID26724316] | Inactive | | | uHTS for 14-3-3/Bad interaction inhibitors [AID781, Type: screening] | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide [Bos taurus [gi:27807367] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | uHTS for 14-3-3/Bad interaction inhibitors | | AID | 781 | | BioAssay type | screening | | Target | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide [Bos taurus [gi:27807367] | | PubMed | | | Data Table |  |
|
| 40 | [SID26724316] | Inactive | | | Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1) [AID1424, Type: screening] | transient receptor potential cation channel, subfamily N, member 1 [Danio rerio] [gi:34330186] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay to identify agonists of the transient receptor potential channel N1 (TRPN1) | | AID | 1424 | | BioAssay type | screening | | Target | transient receptor potential cation channel, subfamily N, member 1 [Danio rerio] [gi:34330186] | | PubMed | | | Data Table |  |
|
| 41 | [SID26724316] | Inactive | Potency | | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 42 | [SID26724316] | Inactive | Potency | | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction [AID1461, Type: confirmatory] | NPSR1 gene product [Homo sapiens] [gi:46395496] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Antagonists of the Neuropeptide S Receptor: cAMP Signal Transduction | | AID | 1461 | | BioAssay type | confirmatory | | Target | NPSR1 gene product [Homo sapiens] [gi:46395496] | | PubMed | | | Data Table |  |
|
| 43 | [SID26724316] | Inactive | | | uHTS for Calpain Inhibitors [AID1236, Type: screening] | calpain II [Sus scrofa] [gi:1628587] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | uHTS for Calpain Inhibitors | | AID | 1236 | | BioAssay type | screening | | Target | calpain II [Sus scrofa] [gi:1628587] | | PubMed | | | Data Table |  |
|
| 44 | [SID26724316] | Inactive | | | uHTS for Calpain Inhibitors [AID1236, Type: screening] | calpain II [Sus scrofa] [gi:1628587] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | uHTS for Calpain Inhibitors | | AID | 1236 | | BioAssay type | screening | | Target | calpain II [Sus scrofa] [gi:1628587] | | PubMed | | | Data Table |  |
|
| 45 | [SID26724316] | Inactive | | | uHTS of small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs) [AID1274, Type: screening] | neutrophil cytosolic factor 1 [Homo sapiens] [gi:115298672] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | uHTS of small molecular inhibitors for p47phox, a regulatory protein of NADPH oxidases (Noxs) | | AID | 1274 | | BioAssay type | screening | | Target | neutrophil cytosolic factor 1 [Homo sapiens] [gi:115298672] | | PubMed | | | Data Table |  |
|
| 46 | [SID26724316] | Inactive | | | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity [AID504582, Type: screening] | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504582 | | BioAssay type | screening | | Target | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] | | PubMed | | | Data Table |  |
|
| 47 | [SID26724316] | Inactive | | | Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2 [AID504621, Type: screening] | HSP90 [Plasmodium falciparum 3D7] [gi:124809506] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | BioAssay | Anti-Malarial Hsp90 Inhibitors Measured in Microorganism System Using Plate Reader - 2121-01_Inhibitor_SinglePoint_HTS_Activity_Set2 | | AID | 504621 | | BioAssay type | screening | | Target | HSP90 [Plasmodium falciparum 3D7] [gi:124809506] | | PubMed | | | Data Table |  |
|
| 48 | [SID26724316] | Inactive | IC50 | | Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP) [AID1619, Type: confirmatory] | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:124809582] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP) | | AID | 1619 | | BioAssay type | confirmatory | | Target | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:124809582] | | PubMed | | | Data Table |  |
|
| 49 | [SID26724316] | Inactive | IC50 | | Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP) [AID1619, Type: confirmatory] | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:124809582] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP) | | AID | 1619 | | BioAssay type | confirmatory | | Target | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:124809582] | | PubMed | | | Data Table |  |
|
| 50 | [SID26724316] | Inactive | IC50 | | Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP) [AID1619, Type: confirmatory] | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:124809582] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 26724316 | | CID | 4412828 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Inhibitors of Plasmodium falciparum M17- Family Leucine Aminopeptidase (M17LAP) | | AID | 1619 | | BioAssay type | confirmatory | | Target | M17 leucyl aminopeptidase [Plasmodium falciparum 3D7] [gi:124809582] | | PubMed | | | Data Table |  |
|